Delivery Order SPE2DB22D1017-SPE2DB25FG6KL
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the diabetes medication Trulicity 1.5 mg/0.5 ml pen, with a ceiling value of $1,351.35 and a completion date of June 26, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity (0.75 mg/0.5 ml pen, 0.5 ml). The contract has a ceiling value of $1,207.74 and a period of performance through July 3, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a ceiling value of $1,683.89 and a period of performance ending on April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract is a firm fixed-price delivery order with a ceiling value of $4,411.65 and a period of performance ending on July 18, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corporation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a firm fixed price of $1,801.80 and a period of performance through April 17, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen with a ceiling value of $1,783.35. The contract has a firm fixed price pricing type and an ultimate completion date of June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1.5 mg/0.5 ml pens of the diabetes medication Trulicity, with a ceiling value of $1,372.00 and a period of performance through June 11, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,139.37, is for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. It is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen, a medication used to treat diabetes. The contract has a ceiling value of $2,902.99 and a period of performance through April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a diabetes medication, with a ceiling value of $2,571.96 and a performance period through May 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6KLDelivery Order
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The Delivery Order has a ceiling value of $1,651.65 and a period of performance through July 3, 2025. The contract is Firm Fixed Price, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/2/25 |